Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Rituximab for Graves' Ophthalmopathy
This study is ongoing, but not recruiting participants.
Study NCT00595335   Information provided by Mayo Clinic

First Received on January 1, 2008.   Last Updated on May 9, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thyroid-associated Ophthalmopathy
Additional conditions recognized in this trial
Eye Diseases
Graves Ophthalmopathy
Thyroid Diseases
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Exophthalmos
Eye Diseases, Hereditary
Goiter
Graves Disease
Hyperthyroidism
Immune System Diseases
Orbital Diseases
Interventions listed in this trial
Rituximab
IV saline
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Rebecca Bahn
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services